126 related articles for article (PubMed ID: 6297502)
1. Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na+ + K+)-ATPase activity.
Schmitz W; Scholz H; Erdmann E; Krawietz W; Werdan K
Biochem Pharmacol; 1982 Dec; 31(23):3853-60. PubMed ID: 6297502
[TBL] [Abstract][Full Text] [Related]
2. The effects of vanadate on rabbit ventricular muscle adenylate cyclase and sodium pump activities.
Aiton JF; Cramb G
Biochem Pharmacol; 1985 May; 34(9):1543-8. PubMed ID: 3846453
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
Nechay BR; Saunders JP
J Environ Pathol Toxicol; 1978; 2(2):247-62. PubMed ID: 216760
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation.
Erdmann E; Krawietz W; Phillipp G; Hackbarth I; Schmitz W; Scholz H
Nature; 1979 Mar; 278(5703):459-61. PubMed ID: 221820
[No Abstract] [Full Text] [Related]
5. Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agent.
Weishaar RE; Quade M; Schenden JA; Boyd DK; Evans DB
Eur J Pharmacol; 1985 Dec; 119(3):205-15. PubMed ID: 3004993
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory effect of vanadate on the adenylate cyclase of cardiac tissue.
Krawietz W; Werdan K; Erdmann E
Biochem Pharmacol; 1979 Aug; 28(16):2517-20. PubMed ID: 228676
[No Abstract] [Full Text] [Related]
7. Effect of palmitoyl carnitine on Na+, K+-ATPase and adenylate cyclase activity of canine myocardial sarcolemma.
Abe M; Yamazaki N; Suzuki Y; Kobayashi A; Ohta H
J Mol Cell Cardiol; 1984 Mar; 16(3):239-45. PubMed ID: 6325716
[TBL] [Abstract][Full Text] [Related]
8. Role of membrane integrity and cation interaction for heart sarcolemmal adenylate cyclase and Na+-K+ ATPase.
Chauhan MS; Anand-Srivastava MB; Panagia V; Dhalla NS
Adv Myocardiol; 1982; 3():317-27. PubMed ID: 6302775
[TBL] [Abstract][Full Text] [Related]
9. Intracellular sodium activity and its regulation in guinea-pig atrial myocardium.
Wang GX; Schmied R; Ebner F; Korth M
J Physiol; 1993 Jun; 465():73-84. PubMed ID: 8229860
[TBL] [Abstract][Full Text] [Related]
10. Low-dose ouabain administration increases Na⁺,K⁺-ATPase activity and reduces cardiac force development in rats.
Meira EF; Siman FD; Faria Tde O; Júnior RF; de Batista PR; Stefanon I; Vassallo DV; Padilha AS
Pharmacol Rep; 2015 Apr; 67(2):253-9. PubMed ID: 25712647
[TBL] [Abstract][Full Text] [Related]
11. Effect of vanadate on cardiac contraction and adenylate cyclase.
Grupp G; Grupp I; Johnson CL; Wallick ET; Schwartz A
Biochem Biophys Res Commun; 1979 May; 88(2):440-7. PubMed ID: 223558
[No Abstract] [Full Text] [Related]
12. Effects of progesterone derivatives on sodium pump activity and force of myocardial contraction in isolated guinea pig heart.
Temma K; Ng YC; Brody TM; Akera T
Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):51-63. PubMed ID: 6194547
[TBL] [Abstract][Full Text] [Related]
13. Effects of vanadate on Na+,K+-ATPase and on the force of contraction in guinea-pig hearts.
Akera T; Takeda K; Yamamoto S; Brody TM
Life Sci; 1979 Nov; 25(21):1803-11. PubMed ID: 231166
[No Abstract] [Full Text] [Related]
14. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
[TBL] [Abstract][Full Text] [Related]
15. Mechanism underlying the strong positive inotropic effects of LND-623: specific inhibition of Na, K-ATPase isoforms and exclusion of cellular sites of contractile control.
Maixent JM; Lelièvre L; Berrebi-Bertrand I
Cardiovasc Drugs Ther; 1998 Dec; 12(6):585-94. PubMed ID: 10410828
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of human cardiac adenylate cyclase by vanadate.
Krawietz W; Werdan K; Erdmann E
Basic Res Cardiol; 1980; 75(3):433-7. PubMed ID: 6905765
[TBL] [Abstract][Full Text] [Related]
17. Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force.
Chen CL; Sangiah S; Patterson E; Berlin KD; Garrison GL; Dunn W; Nan Y; Scherlag BJ; Lazzara R
Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):3-16. PubMed ID: 1334277
[TBL] [Abstract][Full Text] [Related]
18. Control of cardiac sarcolemmal adenylate cyclase and sodium, potassium-activated adenosinetriphosphatase activities.
Tada M; Kirchberger MA; Iorio JM; Katz AM
Circ Res; 1975 Jan; 36(1):8-17. PubMed ID: 123180
[TBL] [Abstract][Full Text] [Related]
19. Evidence against a role of (Na+ + K+)-ATPase in the alpha-adrenoceptor mediated positive inotropic effect of phenylephrine.
Schmitz W; Scholz H; Erdmann E; Werdan K
Experientia; 1980 Nov; 36(11):1313-5. PubMed ID: 6256203
[TBL] [Abstract][Full Text] [Related]
20. Effect of vanadate on myocardial force of contraction.
Scholz H; Hackbarth I; Schmitz W; Wetzel E
Basic Res Cardiol; 1980; 75(3):418-22. PubMed ID: 6905762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
